Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
Add to list
  1. Search results
  2. Negative commercial screening test fo...

Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus

Nicolas Vandenbussche (UGent) , Catherine Cassiman, Maarten Schrooten, Benjamin Gille, Xavier Bossuyt, Thierry Vincent, Philip Van Damme and Koen Poesen
(2017) NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 4(2).
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Vandenbussche, Nicolas, et al. “Negative Commercial Screening Test for Paraneoplastic Antibodies in a Case of Opsoclonus.” NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, vol. 4, no. 2, 2017, doi:10.1212/nxi.0000000000000329.
APA
Vandenbussche, N., Cassiman, C., Schrooten, M., Gille, B., Bossuyt, X., Vincent, T., … Poesen, K. (2017). Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 4(2). https://doi.org/10.1212/nxi.0000000000000329
Chicago author-date
Vandenbussche, Nicolas, Catherine Cassiman, Maarten Schrooten, Benjamin Gille, Xavier Bossuyt, Thierry Vincent, Philip Van Damme, and Koen Poesen. 2017. “Negative Commercial Screening Test for Paraneoplastic Antibodies in a Case of Opsoclonus.” NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION 4 (2). https://doi.org/10.1212/nxi.0000000000000329.
Chicago author-date (all authors)
Vandenbussche, Nicolas, Catherine Cassiman, Maarten Schrooten, Benjamin Gille, Xavier Bossuyt, Thierry Vincent, Philip Van Damme, and Koen Poesen. 2017. “Negative Commercial Screening Test for Paraneoplastic Antibodies in a Case of Opsoclonus.” NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION 4 (2). doi:10.1212/nxi.0000000000000329.
Vancouver
1.
Vandenbussche N, Cassiman C, Schrooten M, Gille B, Bossuyt X, Vincent T, et al. Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2017;4(2).
IEEE
[1]
N. Vandenbussche et al., “Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus,” NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, vol. 4, no. 2, 2017.
@article{8610654,
  articleno    = {{e329}},
  author       = {{Vandenbussche, Nicolas and Cassiman, Catherine and Schrooten, Maarten and Gille, Benjamin and Bossuyt, Xavier and Vincent, Thierry and Van Damme, Philip and Poesen, Koen}},
  issn         = {{2332-7812}},
  journal      = {{NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{2}},
  title        = {{Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus}},
  url          = {{http://dx.doi.org/10.1212/nxi.0000000000000329}},
  volume       = {{4}},
  year         = {{2017}},
}
Altmetric
View in Altmetric